Navigation Links
AZTI-Tecnalia coordinates a platform promoting the use of zebrafish in scientific research
Date:2/18/2009

This release is available in Spanish.

AZTI-Tecnalia is coordinating the First Spanish Technological Platform on the promotion of zebrafish as an animal model in all fields of scientific research. The platform, known as DareNET, has the support of the Spanish Ministry of Science and Innovation through the National Network Programme, and is administered by a Management Board formed by AZTI-Tecnalia, the Andalusian Biology Development Centre (CABD-CSIC), the Biomedical Research Park of Barcelona (PRBB), and the companies ZF BIOLABS and BIOBIDE.

Zebrafish (Danio rerio) is an excellent biological model used in a range of scientific areas spanning from biomedicine, environmental sciences, aquaculture, and food research. The use of the zebrafish is expanding rapidly thanks to its low maintenance costs, its ease of handling and reproduction, its high degree of genetic similarity with higher vertebrates and humans, and to the numerous genetic tools available.

The DareNET platform aims at promoting the use of the zebrafish animal model in Universities, Research Centres and biotechnological companies as an alternative to vertebrate models such as mice, which entail a greater cost and a far more complex handling. Moreover, it aims at specifically training the research personnel who work with this species to create standardized working procedures to consolidate and fostering its use in scientific work.

The DareNET platform has set up a website -www.daniorerio.net- that acts as a forum for sharing knowledge and experience among researchers using the zebrafish animal model .

Lastly, the DareNET platform is seeking to incorporate as members, all the organisations and research teams that use the zebrafish animal model, to become a hub for them all and serve, at the same time, to diffuse the great potential of this model in science and technology at national and international level.


'/>"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. Scientists identify a molecule that coordinates the movement of cells
2. IODP to operate 3 drilling platforms in 2009
3. A new gene silencing platform -- silence is golden
4. WCC Announces Version 6 of its ELISE Smart Search and Match Platform for Employment and Biometric Matching
5. CIC Teams With Industry Leader iPipeline to Provide Electronic Signature Platform to the Nations Top Insurance Carriers
6. Full-Featured Video Analytics Platform Available in Smart Camera Format
7. Fox Chase researchers discover a method for clamping down on a cancer-promoting enzyme
8. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
9. NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays
10. Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
11. Deadly genetic disease prevented before birth in zebrafish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology: